COA Past President Testifies to Congress on Regulatory Pressures on Community Oncology Practices
Dr. David Eagle followed in the footsteps of COA President Dr. Miriam Atkins and Vice President Dr. Debra Patt in testifying to Congress. In testifying to the House Small Business Committee, Dr. Eagle touched on every issue independent community oncology practices face including PBMs, mega health systems, 340B, CMS Stark drug delivery restrictions, low Medicare reimbursement, EMR dysfunction, excessive paperwork and more. You can read Dr. Eagle’s submitted written testimony here. You can listen to a recording of the hearing here, as well.